Inge Derdelinckx

Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

Annemarie M. J. Wensing, David van de Vijver, Gioacchino Angarano et al. · The Journal of Infectious Diseases · 2005 · 420 citations

In Vivo Quantification of Calcitonin Gene-Related Peptide Receptor Occupancy by Telcagepant in Rhesus Monkey and Human Brain Using the Positron Emission Tomography Tracer [11C]MK-4232

Eric D. Hostetler, Aniket Joshi, Sandra Sanabria Bohórquez et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 126 citations

The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes

David van de Vijver, Annemarie M. J. Wensing, Gioacchino Angarano et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · 108 citations · Full text

The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates

Bram Vrancken, Andrew Rambaut, Marc A. Suchard et al. · PLoS Computational Biology · 2014 · 88 citations · Full text

Genetics, Viral Dynamic, Large Transmission Chain +21

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

Karin Hardt, An Vandebosch, Jerald Sadoff et al. · The Lancet Infectious Diseases · 2022 · 84 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +7